![](/img/cover-not-exists.png)
Radium-223 (Ra-223) in sequence or in concurrent use with abiraterone acetate (AA) or enzalutamide (E) in metastatic castration resistant prostate cancer (mCRPC) patients treated in an international early access program (iEAP)
Saad, F., Heinrich, D., Gillessen, S., O’Sullivan, J., Carles, J., Wirth, M., Miller, K., Huang, L., Seger, M., Nilsson, S., Heidenreich, A.Volume:
16
Language:
english
Journal:
European Urology Supplements
DOI:
10.1016/S1569-9056(17)30124-0
Date:
March, 2017
File:
PDF, 218 KB
english, 2017